Skip to Main Content

Liability Medicare Set Asides – Bracing for the storm

Updated March 3, 2022

For years, the Liability Medicare Set-Aside (LMSA) issue has been the source of much debate and frustration for liability claims payers. To date, there remain lingering questions on several fronts and the Centers for Medicare and Medicaid Services’ (CMS) attempts to clarify these issues that have been generally viewed as inadequate. As a result, liability claims payers have been left to navigate the uncertainties the best they can—while preparing for where CMS may be heading next.

In March 2022, the Office of Information and Regulatory Affairs (OIRA released a notice indicating that CMS’s long-awaited “Future Medicals” proposals have been completed and are now pending OIRA review for release.  Prior to this March 2022 OIRA notice, CMS had projected the release of their “Future Medicals” proposals at various points in 2019, February 2020, August 2020, March 2021, October 2021, and most recently February 2022.  See our article CMS on the move: Section 111 civil money penalties Final Rule and Future Medicals proposals are pending review for release for more information.

Kendal L4ikccachoc Unsplash

While we await CMS’ next steps, there is time to sneak in a quick level-set focusing on where we have been, where we are now, and where CMS may be headed regarding LMSAs.  

Toward this goal, the author provides the following overview:

Town Hall statements

Perhaps the logical starting point is to attempt to piece together how CMS views the issue. On this point, the industry forced CMS out of its silence during the early days of its Section 111 Town Hall calls almost a decade ago. Although these calls were designated to discuss Section 111 reporting (which is unrelated to the LMSA issue), CMS was barraged with questions regarding LMSAs.

These exchanges provided the first glimpses into CMS’ perspective on LMSAs. For example, in a September 2009 Town Hall, CMS expressed the view that the “underlying statutory obligation” was the “same” for liability and workers’ compensation cases when it came to protecting Medicare’s future medicals interests.[1] Further, CMS explained that while it did not have a formal LMSA review process — or that a CMS regional office declined to review an LMSA proposal — this did not provide “any type of safe harbor.”[2] CMS cautioned not to confuse the issue of “process” (that is, whether its MSA review process was or was not available for liability claims) with the underlying “obligation” to protect its interests.[3]

In a January 2010 Town Hall, CMS honed its position further stating: “set-asides [in] liability situations are not required in terms of CMS being involved in…determination of how much the set-aside should be…This is not the same thing as a blanket statement that liability set-asides are simply not required or not appropriate. Regardless of the mechanism, Medicare’s interests need to be protected. The statute says that we don’t make payment where payment has already been made.”[4]  

Whether these types of agency statements should be considered authoritative, ushers in a whole litany of deeper issues and questions beyond the scope of this analysis. However, these statements, at face value at least, shed some light on CMS’ thinking (right or wrong).

LMSA memo (September 2011)

CMS’ Town Hall statements raised concerns on many levels, prompting calls for further clarification. CMS responded with its much-anticipated September 30, 2011, “LMSA memorandum.”[5] There was guarded optimism this memo would provide better clarity and guidance; however, the release fell far short of both goals. Specifically, CMS simply outlined when it viewed an LMSA as unnecessary— situations where a claimant’s treating physician certifies in writing that treatment has concluded and no further treatment for the alleged injuries is required.[6] This memo, which remains in effect today, was widely criticized as too limited in scope and imposing a largely unrealistic evidentiary requirement.   

Proposed regulations (2012-2014)

CMS then upped the ante in 2012 by releasing its Advanced Notice of Proposed Rulemaking (ANPRM).[7] This was an attempt to implement formal legal rules concerning future medicals for liability claims into the Code of Federal Regulations. In September 2013, CMS announced plans to release a Notice of Proposed Rulemaking (NPRM) as its next step regarding the ANPRM proposals.[8] To date, CMS’ 2012 ANPRM has been the agency’s most serious foray into the issue. 

In support of its proposals, CMS proceeded from the position that Medicare was prohibited from making payment under the MSP when payment has been made via settlement and that Medicare remained the secondary payer until the settlement was exhausted.[9] Further, CMS stated it was entitled to recover conditional payments related to settlements “regardless of when the items and services are provided.”[10]

As for the actual proposals, the 2012 ANPRM was a complex set of rules governing when and how CMS’ future medical interests were to be addressed as part of liability settlements, which included possible plans for a formal LMSA review process.[11] For unknown reasons, these proposals were withdrawn in fall 2014.

Waiting for CMS’ new proposals

This long and winding road leads us to current state – waiting for CMS’ new round of future medicals proposals.

In this regard, the Office of Regulatory Affairs (OIRA) released a Fall 2021 update notice indicating that CMS plans on releasing a new NPRM in February 2022 aimed at addressing future medicals, with said notice stating as follows:

This proposed rule would clarify existing Medicare Secondary Payer (MSP) obligations associated with future medical items services related to liability insurance (including self-insurance), no fault insurance, and worker’s compensation settlements, judgments, awards, or other payments. This proposed rule would also remove obsolete regulations. 

Of note, the OIRA’s new notice eliminated the following verbiage which was contained in its Spring 2021 notice: “Specifically, this rule would clarify that an individual or Medicare beneficiary must satisfy Medicare’s interest with respect to future medical items and services related to such settlements, judgments, awards, or other payments.”[12]  It is unknown whether the elimination of this verbiage will ultimately have any type of significance. 

It is widely anticipated that the forthcoming NPRM proposals will concentrate on future medical obligations concerning liability claims (i.e., LMSAs). However, the OIRA’s latest notice also references no-fault and workers’ compensation. Thus, we will need to wait to see CMS’s actual NPRM proposals to examine the exact proposals relative to the various insurance lines referenced.

After CMS releases its proposals…then what?

In conjunction with release of the forthcoming NPRM, CMS will provide a “comment period” where the public will have a certain timeframe (typically 60 days) to submit commentary response to the proposals. From there, CMS will assess and consider the received comments to help formulate its final regulations for implementation. 

In terms of preparing to analyze the proposals, three questions arise:

First, “what” is CMS contemplating from substantive standpoint? That is, questions surrounding such issues as: Which party will be responsible for complying with its regulations? Which claims will be included (and excluded)? Will there be monetary thresholds? How will CMS account for specific liability claims realities – such as comparative fault, policy limits, caps, and discounted settlements? Will no-fault or med-pay claims be at play? Will there be penalties or other forms of potential liability for improper compliance?

Second, “how” does CMS plan to implement its proposals? On this question, the fact that CMS plans to issue a NPRM suggests it intends to implement formal regulations into the Code of Regulations. Outside of that, it is unknown how what CMS has in store in terms of how it will all work. For example, will CMS establish some form of review/approval process? Will there be rules around the calculation of future medical allocations, funding, or administration?

Finally, “when” does CMS plan on implement its rules? On this point, it would seem logical to assume that CMS’ rules will have prospective application.

How CMS addresses these key questions will need to be carefully analyzed and will serve as the likely focal points for commentary response. 

Also, as was the case with CMS’ 2012 proposals, it is expected that many commentary responses will question CMS’ actual underlying statutory authority to regulate future medicals for liability claims. While this issue is outside the scope of this review, questions will likely be raised regarding CMS’ authority to implement future medicals regulations without Congress first amending the Medicare secondary payer statute (MSP). On this point, there has been several case decisions over the past few years either calling into question whether the MSP or current federal regulations require LMSAs. See e.g., Silva v. Burwell, 2017 WL 5891753 (D. N.M. 2017); Sipler v. Trans Am Trucking, Inc., 881 F.Supp. 2d 635 (D. N.J. 2012); Bruton v. Carnival Corporation, 2012 WL 1627729 (S.D. Fla. 2012); Abate v. Wal-Mart Stores East, L.P., 2020 WL 7027481 (W.D. Pa. November 30, 2020); and Stillwell v. State Farm, et. al., 2021 WL 4427081 (M.D. Fla., September 27, 2021). 

Please contact the author directly if you have any questions or would like assistance in analyzing CMS’ proposals when they are released.

[1] CMS, Town Hall Teleconference Transcript, Section 111 of the Medicare, Medicaid & SCHIP Extension Act of 2017, Call Date: September 30, 2009, p. 25-26.

[2] Id.

[3] Id.

[4] CMS, Town Hall Teleconference Transcript, Section 111 of the Medicare, Medicaid & SCHIP Extension Act of 2017, Call Date: January 28, 2010, p. 17.

[5] CMS Memorandum (Charlotte Benson – Acting Director), Medicare Secondary Payer—Liability Insurance (Including Self-Insurance) Settlements, Judgments, Awards, or Other Payments and Future Medicals – INFORMATION, September 30, 2011.

[6] Id.

[7] Centers for Medicare and Medicaid Services, Medicare Secondary Payer and “Future Medicals,” CMS-6047-ANRPM, 77 F.R. 3917 (June 15, 2012). 

[8] See, Office of Information and Regulatory Affairs, Medicare Secondary Payer and "Future Medicals" (CMS-6047-P), Spring 2013.

[9] Centers for Medicare and Medicaid Services, Medicare Secondary Payer and “Future Medicals,” CMS-6047-ANRPM, 77 F.R. at 3918.

[10] Id.

[11] Id. at p, 35919-35921.

[12] OIRA’s Spring 2021 notice:

Mark Popolizio, J.D.

Mark Popolizio, J.D., is vice president of MSP compliance, Casualty Solutions at Verisk. You can contact Mark at

Visualize Subscribe

Get the best of Visualize!

We'll send Visualize Monthly, and our most popular content, right to your inbox.

Subscribe now

You will soon be redirected to the 3E website. If the page has not redirected, please visit the 3E site here. Please visit our newsroom to learn more about this agreement: Verisk Announces Sale of 3E Business to New Mountain Capital.